About Women's Health Market
Women’s health refers to the overall well-being experienced by women — this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). It also includes issues other than the biological conditions, like gender inequality (women are sometimes not able to afford medical treatments) or other socioeconomic issues.
Technavio’s analysts forecast the global women's health market to grow at a CAGR of 3.84% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global women's health market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of drugs and devices for women's health issues.
The market is divided into the following segments based on geography:
• Americas
• APAC
• Europe
• MEA
Technavio's report, Global Women's Health Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Allergan
• Bayer HealthCare
• Merck
• Pfizer
• Teva Pharmaceuticals
Other prominent vendors
• Agile Therapeutics
• Amgen
• Apothecus Pharmaceutical
• AstraZeneca
• Blairex Laboratories
• Bristol-Myers Squibb
• EffRx
• Ferring International Center
• GlaxoSmithKline
• HLL Lifecare
• Janssen Pharmaceutical
• Lipocine
• Ligand Pharmaceuticals
• Lupin Pharmaceuticals
• Mayer Laboratories
• Medicines 360
• Neurocrine Biosciences
• Novartis
• Novo Nordisk
• Pantarhei Bioscience
• Sanofi
Market driver
• Rise in number of older women worldwide
• For a full, detailed list, view our report
Market challenge
• High cost and inaccessibility of health services
• For a full, detailed list, view our report
Market trend
• Rise in STIs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• Market overview
• Global postmenopausal osteoporosis market
• Global contraceptives market
• Global infertility market
• Global menopause market
• Global endometriosis market
• Global polycystic ovary syndrome market
PART 07: Geographical segmentation
• Market overview
• Women's health market in Americas
• Women's health market in Europe
• Women's health market in APAC
• Women's health market in MEA
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• Allergan
• Bayer HealthCare
• Merck
• Pfizer
• Teva Pharmaceuticals
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
?
List of Exhibits
Exhibit 01: Global women's health market segmentation
Exhibit 02: Product offerings
Exhibit 03: Global women's health market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global women's health market segmentation by application 2015
Exhibit 06: Global women's health market segmentation by application 2020
Exhibit 07: Global women's health market by application 2015-2020 ($ billions)
Exhibit 08: Global women's health market by application 2015-2020 (% share)
Exhibit 09: Global postmenopausal osteoporosis market 2015-2020 ($ billions)
Exhibit 10: Global contraceptives market 2015-2020 ($ billions)
Exhibit 11: Global infertility market 2015-2020 ($ billions)
Exhibit 12: Global menopause market 2015-2020 ($ billions)
Exhibit 13: Global endometriosis market 2015-2020 ($ billions)
Exhibit 14: Global polycystic ovary syndrome market 2015-2020 ($ millions)
Exhibit 15: Global women's health market geographical segmentation 2015
Exhibit 16: Global women's health market geographical segmentation 2015-2020 ($ billions)
Exhibit 17: Women's health market in Americas 2015-2020 ($ billions)
Exhibit 18: Women's health market in Europe 2015-2020 ($ billions)
Exhibit 19: Women's health market in APAC 2015-2020 ($ billions)
Exhibit 20: Women's health market in MEA 2015-2020 ($ billions)
Exhibit 21: Average annual per capita growth in health spending and share of GDP in emerging countries and OECD for 2013-2014
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Companies focusing on women’s health
Exhibit 25: Allergan: Key takeaways
Exhibit 26: Bayer HealthCare: Key takeaways
Exhibit 27: Merck: Key takeaways
Exhibit 28: Pfizer: Key takeaways
Exhibit 29: Teva Pharmaceuticals: Key takeaways
